Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
$4.5M Sell
81,946
-625
-0.8% -$33.3K 1.29% 24
2016
Q1
$4.17M Sell
82,571
-715
-0.9% -$35K 1.22% 25
2015
Q4
$4.2M Sell
83,286
-3,158
-4% -$159K 1.17% 26
2015
Q3
$4.07M Sell
86,444
-2,540
-3% -$135K 1.07% 27
2015
Q2
$4.83M Sell
88,984
-177
-0.2% -$9.93K 1.08% 26
2015
Q1
$4.89M Sell
89,161
-1,189
-1% -$67.3K 1.08% 24
2014
Q4
$4.9M Sell
90,350
-718
-0.8% -$40K 1.05% 26
2014
Q3
$5.15M Sell
91,068
-1,153
-1% -$64.7K 1.09% 25
2014
Q2
$5.09M Sell
92,221
-5,763
-6% -$314K 1.05% 26
2014
Q1
$5.31M Sell
97,984
-8,476
-8% -$439K 1.06% 25
2013
Q4
$5.08M Sell
106,460
-3,932
-4% -$180K 0.98% 27
2013
Q3
$5.01M Sell
110,392
-120
-0.1% -$5.48K 1.07% 22
2013
Q2
$4.9M Buy
+110,512
New +$4.94M 1.03% 25

Other funds holding MRK

First Niagara Bank's MRK Position: Q2 2016 in Review

First Niagara Bank reduced its Merck (MRK) stake by 0.76% in Q2 2016, selling an estimated $33.3K and leaving 81,946 shares worth $4.5M. The position accounts for 1.29% of the portfolio, ranked #24.

First Niagara Bank first reported a position in MRK in Q2 2013 and has held it in 13 quarters since. The position peaked at $5.31M in Q1 2014. 1,762 funds tracked by Wall St. Rank hold MRK as of Q2 2016.

  • First Niagara Bank held 81,946 shares of Merck worth $4.5M as of Q2 2016.
  • First Niagara Bank sold 625 Merck shares in Q2 2016, an estimated $33.3K.
  • Merck made up 1.29% of First Niagara Bank's portfolio in Q2 2016, its #24 holding.
  • First Niagara Bank first reported a position in Merck in Q2 2013 and has held it in 13 quarters since.
  • First Niagara Bank's Merck position peaked at $5.31M in Q1 2014.
  • 1,762 funds tracked by Wall St. Rank held Merck as of Q2 2016.

Based on First Niagara Bank's 13F filing for Q2 2016, filed 25 Jul 2016.